Search results Showing 5 of 264 results
Using new drug combinations to reduce side effects whilst controlling lung cancer better
| Lead researcher: |
Prof Kairbaan Hodivala-Dilke |
| Research area: |
Cancer |
| Disease or condition: |
Lung cancer |
| Research organisation: |
Queen Mary University |
| Funding type: |
Research grant |
| Status: |
Awarded and preparing to start |
| Amount: |
£313,579 |
Read more
A preclinical study into the anti-tumour and side effect profile of novel therapy for the childhood cancer neuroblastoma
| Lead researcher: |
Dr Elizabeth Tucker |
| Research area: |
Cancer |
| Disease or condition: |
Neuroblastoma |
| Research organisation: |
Institute of Cancer Research |
| Funding type: |
Research grant |
| Status: |
Awarded and preparing to start |
| Amount: |
£303,037 |
Read more
How do white blood cells cause side-effects during checkpoint cancer treatment
| Lead researcher: |
Prof David Bending |
| Research area: |
Cancer |
| Disease or condition: |
Immunotherapy side effects |
| Research organisation: |
University of Birmingham |
| Funding type: |
Research grant |
| Status: |
Awarded and preparing to start |
| Amount: |
£398,835 |
Read more
What are the long-term effects of CAR T-Cell Therapy on memory, thinking, and mental health?
| Lead researcher: |
Dr Thomas Pollak |
| Research area: |
Cancer |
| Disease or condition: |
Immunotherapy side effects |
| Research organisation: |
King's College London |
| Funding type: |
Research grant |
| Status: |
Awarded and preparing to start |
| Amount: |
£484,003 |
Read more
Preventing liver damage in patients with leukaemia treated with Inotuzumab Ozogamicin and Gemtuzumab Ozogamicin
| Lead researcher: |
Dr Richard Burt |
| Research area: |
Cancer |
| Disease or condition: |
leukaemia |
| Research organisation: |
Imperial College London |
| Funding type: |
Research grant |
| Status: |
Awarded and preparing to start |
| Amount: |
£507,317 |
Read more